133 related articles for article (PubMed ID: 15637681)
1. Atypical papillary proliferation in gynecologic patients: a study of 32 pelvic washes.
Ventura KC; Yang GC; Levine PH
Diagn Cytopathol; 2005 Feb; 32(2):76-81. PubMed ID: 15637681
[TBL] [Abstract][Full Text] [Related]
2. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
Sadeghi S; Ylagan LR
Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
[TBL] [Abstract][Full Text] [Related]
3. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
Selvaggi SM
Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
[TBL] [Abstract][Full Text] [Related]
5. [Stage I ovarian carcinoma: two distinct malignancies?].
Deligdisch L
Bull Acad Natl Med; 2007 Nov; 191(8):1695-700; discussion 1700-1. PubMed ID: 18666467
[TBL] [Abstract][Full Text] [Related]
6. Pelvic washing cytology of ovarian Sertoli-Leydig-cell tumor with retiform pattern: a case report.
Guo M; Lim JC; Wojcik EM
Diagn Cytopathol; 2003 Jul; 29(1):28-30. PubMed ID: 12827712
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms.
Ziselman EM; Harkavy SE; Hogan M; West W; Atkinson B
Acta Cytol; 1984; 28(2):105-10. PubMed ID: 6583966
[TBL] [Abstract][Full Text] [Related]
8. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
10. The relationship between papillary infarction and microinvasion in ovarian atypical proliferative ("borderline") serous and seromucinous tumors.
Kraus JA; Seidman JD
Int J Gynecol Pathol; 2010 Jul; 29(4):303-9. PubMed ID: 20567140
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases.
Stewart CJ; Brennan BA; Hammond IG; Leung YC; McCartney AJ
Int J Gynecol Pathol; 2006 Jul; 25(3):216-22. PubMed ID: 16810056
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases.
Khunamornpong S; Lerwill MF; Siriaunkgul S; Suprasert P; Pojchamarnwiputh S; Chiangmai WN; Young RH
Int J Gynecol Pathol; 2008 Jul; 27(3):366-79. PubMed ID: 18580314
[TBL] [Abstract][Full Text] [Related]
13. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
14. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
15. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
16. Stage I ovarian carcinoma: different clinical pathologic patterns.
Deligdisch L; Pénault-Llorca F; Schlosshauer P; Altchek A; Peiretti M; Nezhat F
Fertil Steril; 2007 Oct; 88(4):906-10. PubMed ID: 17920404
[TBL] [Abstract][Full Text] [Related]
17. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
18. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
[TBL] [Abstract][Full Text] [Related]
19. Cytologic findings in peritoneal washings associated with benign gynecologic disease.
Zuna RE; Mitchell ML
Acta Cytol; 1988; 32(2):139-47. PubMed ID: 3348055
[TBL] [Abstract][Full Text] [Related]
20. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
